Literature DB >> 15017569

Rotavirus-associated necrotizing enterocolitis: an insight into a potentially preventable disease?

Renu Sharma1, Robert D Garrison, J J Tepas, Daniel L Mollitt, Pam Pieper, Mark L Hudak, James A Bradshaw, Gary Stevens, Bangalore R Premachandra.   

Abstract

PURPOSE: The aim of this study was to test the hypothesis that rotavirus-associated necrotizing enterocolitis (NEC + RV) differs from NEC associated with other organisms (NEC-RV).
METHODS: Neonates with modified Bell stage II or higher NEC were identified. Demographic, clinical, and outcome information was collected prospectively. Fecal specimens from all infants were tested for confirmation of rotavirus infection (RVI) by immunoelectron microscopy (IEM).
RESULTS: Of 2,444 admissions in the neonatal intensive care unit (NICU), 129 (5.3%) had NEC. Thirty-eight (29%) were rotavirus positive. The 2 groups did not differ in maternal or neonatal characteristics. Stage III or higher NEC was more common in the NEC-RV infants (62% v. 39%; P =.032), whereas recurrence was more common in NEC + RV group (P <.0001). The predominant distribution of nondiffuse pneumatosis (n = 52) was right sided in NEC-RV group and left sided in NEC + RV group (P <.0001). Surgical intervention (SI) did not differ between the 2 groups. The complications and mortality rates also were similar. Severe pneumatosis (P =.009) and severe thrombocytopenia (Platelet count < 50,000/mm3; P <.0001) increased, while human milk feedings decreased (P =.022) the odds for surgery. The annual distribution of NEC + RV paralleled RVI in the community.
CONCLUSIONS: Generally, NEC + RV is a less severe disease than NEC - RV as classified by modified Bell staging. However, it can reach advanced stages obscuring distinction from NEC - RV. Indications for surgery should not be altered by identification of RVI in these infants. Monitoring RVI in the community, adhering to infection control measures, human milk feedings, and improving neonatal immunity against RVI may reduce the incidence of NEC + RV.

Entities:  

Mesh:

Year:  2004        PMID: 15017569     DOI: 10.1016/j.jpedsurg.2003.11.016

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  17 in total

Review 1.  Oral immunoglobulin for the prevention of rotavirus infection in low birth weight infants.

Authors:  Mohan Pammi; Khalid N Haque
Journal:  Cochrane Database Syst Rev       Date:  2011-11-09

2.  Complications in hospitalized children with acute gastroenteritis caused by rotavirus: a retrospective analysis.

Authors:  Petra Kaiser; Michael Borte; Klaus-Peter Zimmer; Hans-Iko Huppertz
Journal:  Eur J Pediatr       Date:  2011-08-11       Impact factor: 3.183

Review 3.  [Viral acute diarrhea: clinical and evolutive aspects].

Authors:  J-P Olives; E Mas
Journal:  Arch Pediatr       Date:  2007-10       Impact factor: 1.180

4.  Temporal and seasonal variations in incidence of stage II and III NEC-a 28-year epidemiologic study from tertiary NICUs in Connecticut, USA.

Authors:  Darius Javidi; Zigeng Wang; Sanguthevar Rajasekaran; Naveed Hussain
Journal:  J Perinatol       Date:  2021-02-15       Impact factor: 2.521

5.  Neonatal gut injury and infection rate: impact of surgical debridement on outcome.

Authors:  Renu Sharma; Joseph J Tepas; Mark L Hudak; Pam Pieper; Ru-Jeng Teng; Savithri Raja; Monica Sharma
Journal:  Pediatr Surg Int       Date:  2005-10-07       Impact factor: 1.827

6.  The association between enteric viruses and necrotizing enterocolitis.

Authors:  Chen Cheng; Yu He; Sa Xiao; Qing Ai; Jialin Yu
Journal:  Eur J Pediatr       Date:  2020-07-22       Impact factor: 3.183

7.  Clinical characteristics of viral intestinal infection in preterm and term neonates.

Authors:  S Bagci; A M Eis-Hübinger; A F Yassin; A Simon; P Bartmann; A R Franz; A Mueller
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-06-20       Impact factor: 3.267

8.  The coincidence of necrotizing enterocolitis and rotavirus infections and potential associations with cytokines.

Authors:  Efsun Sızmaz; Mehmet Satar; Ferda Ozlü; Akgün Yaman; Hacer Yapıcıoğlu Yıldızdaş; Kenan Ozcan
Journal:  Can J Infect Dis Med Microbiol       Date:  2012       Impact factor: 2.471

Review 9.  Pentavalent human-bovine (WC3) reassortant rotavirus vaccine in special populations: a review of data from the Rotavirus Efficacy and Safety Trial.

Authors:  M Van der Wielen; P Van Damme
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-03-20       Impact factor: 3.267

10.  Mapping the New World of Necrotizing Enterocolitis (NEC): Review and Opinion.

Authors:  Phillip Gordon; Robert Christensen; Jörn-Hendrik Weitkamp; Akhil Maheshwari
Journal:  EJ Neonatol Res       Date:  2012
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.